Your browser doesn't support javascript.
loading
The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia.
Boyiadzis, Michael M; Aksentijevich, Ivan; Arber, Daniel A; Barrett, John; Brentjens, Renier J; Brufsky, Jill; Cortes, Jorge; De Lima, Marcos; Forman, Stephen J; Fuchs, Ephraim J; Fukas, Linda J; Gore, Steven D; Litzow, Mark R; Miller, Jeffrey S; Pagel, John M; Waller, Edmund K; Tallman, Martin S.
Afiliação
  • Boyiadzis MM; Department of Medicine, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA boyiadzism@upmc.edu.
  • Aksentijevich I; Virginia Cancer Specialists, Fairfax, Virginia, USA.
  • Arber DA; Department of Pathology, University of Chicago, Chicago, Illinois, USA.
  • Barrett J; Stem Cell Allotransplantation Section, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Brentjens RJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Brufsky J; Department of Medicine, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Cortes J; Department of Medicine, Division of Hematology/Oncology, Georgia Cancer Center, Augusta, Georgia, USA.
  • De Lima M; Division of Hematology, University Hospitals of Cleveland and Case Western Reserve University, Cleveland, Ohio, USA.
  • Forman SJ; Hematologic Malignancies Research Institute, City of Hope National Medical Center, Duarte, California, USA.
  • Fuchs EJ; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Fukas LJ; Clinical Research Services, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Gore SD; Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA.
  • Litzow MR; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Miller JS; Division of Hematology, Oncology and Transplantation, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA.
  • Pagel JM; Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, Washington, USA.
  • Waller EK; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
  • Tallman MS; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
J Immunother Cancer ; 8(2)2020 10.
Article em En | MEDLINE | ID: mdl-33077513
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Imunoterapia Tipo de estudo: Guideline Limite: Humans / Male Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Imunoterapia Tipo de estudo: Guideline Limite: Humans / Male Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article